BSV has always
recognized the criticality of R&D and hence has extensively
focused on building in-house R&D capabilities to develop
drugs which are:
Developing non infringing / superior
Novel Drug Delivery Systems and create IPR
Use emerging tools of biotechnology
for new products - recombinant products and monoclonal
antibodies
Cost effective
Provide enormous benefits over the
existing therapy
Improve existing products / processes
Substantial investments
have been made in R&D Infrastructure including high quality
laboratory facilities, experienced research scientists and
personnel. Investments made in R&D by the Company has
been at par with international R&D spending at approximate
7% of turnover. The Research and Development activities of
the Company have been granted recognition by the Department
of Scientific and Industrial Research, Ministry of Science
and Technology, Govt. of India.
Today BSV has three distinct R&D divisions working extensively
on:
Sitemap